DPW
MRNA icon

DiNuzzo Private Wealth’s Moderna MRNA Stock Holding History

DiNuzzo Private Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1K Buy
30
+7
+30% +$362 ﹤0.01% 658
2026
Q1 		$1.17K Buy
+23
New +$1.07K ﹤0.01% 831
2025
Q2 		– Sell
-1
Closed -$29 – 1391
2025
Q1 		$29 Sell
1
-1
-50% -$35 ﹤0.01% 1354
2024
Q4 		$84 Sell
2
-16
-89% -$765 ﹤0.01% 1345
2024
Q3 		$1.2K Sell
18
-3
-14% -$275 ﹤0.01% 791
2024
Q2 		$2.49K Buy
21
+5
+31% +$633 ﹤0.01% 443
2024
Q1 		$1.71K Sell
16
-1
-6% -$101 ﹤0.01% 530
2023
Q4 		$1.69K Buy
+17
New +$1.43K ﹤0.01% 509

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

DiNuzzo Private Wealth's MRNA Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Moderna (MRNA) stake by 30% in Q2 2026, buying an estimated $362 and bringing the position to 30 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

DiNuzzo Private Wealth first reported a position in MRNA in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.49K in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • DiNuzzo Private Wealth held 30 shares of Moderna worth $2.1K as of Q2 2026.
  • DiNuzzo Private Wealth bought 7 Moderna shares in Q2 2026, an estimated $362.
  • Moderna made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #658 holding.
  • DiNuzzo Private Wealth first reported a position in Moderna in Q4 2023 and has held it in 8 quarters since.
  • DiNuzzo Private Wealth's Moderna position peaked at $2.49K in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.